AI-assisted scoping review of code sharing in clinical prediction model research. Publication: Nature Medicine. Dana-Farber Cancer Institute authors: ...

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

An investigational antibody-drug conjugate demonstrated clinically meaningful and durable responses in patients with platinum-resistant ovarian cancer, including patients whose tumors had low or no ...

Boston's renowned Longwood Medical Area (LMA) is one of the world's foremost hubs of advanced medical care and breakthrough research. It is here that Dana-Farber established our headquarters, and it ...

Dr. Lakshmi Nayak serves as Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She received her ...

Dana-Farber's Online Second Opinion Program for adult patients is powered by AccessHope. Once materials collection is complete, it typically takes 7 to 14 business days to receive your written online ...

What Is Soft Tissue Sarcoma? Soft tissue sarcoma refers to cancer that begins in the muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. The tumors can be found ...

Neha Garg, MD - Medical Oncology Dana-Farber Brigham Cancer Center at South Shore Health 101 Columbian Street South Weymouth, MA 02190 ...

The Multiple Myeloma Program within the Hematologic Oncology Treatment Center includes physicians, clinicians, and research scientists who work together on promising new therapies. Your care team will ...

Our Center for Esophageal and Gastric Cancer includes medical, surgical, and radiation oncologists, gastroenterologists, radiologists, and pathologists who improve the outcome for patients with ...

Dr. Murakami graduated from Washington University School of Medicine with an M.D. and M.A. in Biology and Biomedical Sciences in 2009. He trained in Internal Medicine at the Massachusetts General ...

A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer ...